Lingling Zu

1.1k citations
54 papers · 834 · h-index 16

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Physiology top 10%
    • Adenosine and Purinergic Signaling

Papers in

    • Lung Cancer Research Studies 9
    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Cells and Metastasis 2
    • MicroRNA in disease regulation 11

Lingling Zu

52 papers receiving 820 citations

Peers

Lingling Zu
Comparison fields: 5 of 61
  • Cancer Research 328
  • Physiology 42
  • Oncology 152
  • Pulmonary and Respiratory Medicine 117
  • Drug Discovery 1
Replace Yu Qi with:
Yu Qi China
Ruth Glas United States
Takashi Mitamura Japan
Zaozao Wang China
Ying-Hui Zhu China
Mirella Giordano Italy
James E. Ferguson United States
Lingling Zu relative to Yu Qi China Yu Qi's profile →
Citations per field
00.5×2×3×3.8×
Yu Qi · 1×
Citations per year

Countries citing papers authored by Lingling Zu

Since Specialization
Citations

This map shows the geographic impact of Lingling Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Zu more than expected).

Fields of papers citing papers by Lingling Zu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Zu. The network helps show where Lingling Zu may publish in the future.

Co-authors

The 25 scholars most cited alongside Lingling Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lingling Zu Line = papers co-authored together Lingling Zu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201494
2
Erratum: MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.
201670
3 201460
4 201358
5 201546
6 201736
7
MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.
201535
8 201634
9 201429
10 202029
11 202222
12 202321
13 202119
14 202219
15 202319
16 202117
17 202116
18 201415
19 202115
20 202214

About Lingling Zu

Lingling Zu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Geriatrics and Gerontology, having authored 54 papers that have together received 834 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Cells and Metastasis (2 papers) and Mechanisms of cancer metastasis (2 papers). The work is most often cited by research in Cancer Research (328 citations), Physiology (42 citations), Oncology (152 citations), Pulmonary and Respiratory Medicine (117 citations) and Drug Discovery (1 citation). Lingling Zu has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Yang Li, Jiacong You, Song Xu, Qinghua Zhou, Qinghua Zhou, Xuebing Li, Jun Du, Qing Yang, Ning Zhou and Qinghua Zhou. Their work appears in journals such as Cancer Medicine, Frontiers in Oncology, Cancers, BMC Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact